A detailed history of Home Federal Bank Of Tennessee transactions in Abb Vie Inc. stock. As of the latest transaction made, Home Federal Bank Of Tennessee holds 17,695 shares of ABBV stock, worth $3.28 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
17,695
Previous 17,705 0.06%
Holding current value
$3.28 Million
Previous $3.22 Million 5.86%
% of portfolio
0.93%
Previous 1.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $1,547 - $1,807
-10 Reduced 0.06%
17,695 $3.04 Million
Q1 2024

Apr 17, 2024

SELL
$159.82 - $182.1 $3,995 - $4,552
-25 Reduced 0.14%
17,705 $3.22 Million
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $6,880 - $7,748
-50 Reduced 0.28%
17,730 $2.75 Million
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $2,671 - $3,093
-20 Reduced 0.11%
17,780 $2.65 Million
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $36,440 - $45,347
275 Added 1.57%
17,800 $2.4 Million
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $1,446 - $1,665
-10 Reduced 0.06%
17,525 $2.79 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $11,756 - $14,098
-85 Reduced 0.48%
17,535 $0
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $8,723 - $10,005
-65 Reduced 0.37%
17,620 $2.37 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $24,771 - $31,492
180 Added 1.03%
17,685 $2.71 Million
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $20,324 - $25,217
-154 Reduced 0.87%
17,505 $2.84 Million
Q4 2021

Jan 12, 2022

SELL
$107.43 - $135.93 $12,891 - $16,311
-120 Reduced 0.67%
17,659 $2.39 Million
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $5,852 - $6,642
55 Added 0.31%
17,779 $1.92 Million
Q2 2021

Jul 13, 2021

SELL
$105.21 - $117.21 $123,832 - $137,956
-1,177 Reduced 6.23%
17,724 $2 Million
Q1 2021

Apr 09, 2021

BUY
$102.3 - $112.62 $9,104 - $10,023
89 Added 0.47%
18,901 $2.05 Million
Q4 2020

Jan 11, 2021

BUY
$80.49 - $108.67 $18,432 - $24,885
229 Added 1.23%
18,812 $2.02 Million
Q3 2020

Oct 09, 2020

SELL
$85.91 - $100.83 $6,443 - $7,562
-75 Reduced 0.4%
18,583 $1.63 Million
Q2 2020

Jul 08, 2020

BUY
$73.37 - $98.18 $1,173 - $1,570
16 Added 0.09%
18,658 $1.83 Million
Q1 2020

Apr 10, 2020

SELL
$64.5 - $97.79 $13,545 - $20,535
-210 Reduced 1.11%
18,642 $1.42 Million
Q4 2019

Jan 13, 2020

SELL
$72.13 - $90.25 $9,016 - $11,281
-125 Reduced 0.66%
18,852 $1.67 Million
Q3 2019

Oct 10, 2019

BUY
$62.98 - $75.72 $5,668 - $6,814
90 Added 0.48%
18,977 $1.44 Million
Q2 2019

Jul 11, 2019

SELL
$65.7 - $83.98 $854 - $1,091
-13 Reduced 0.07%
18,887 $1.37 Million
Q1 2019

Apr 16, 2019

SELL
$77.14 - $90.79 $5,785 - $6,809
-75 Reduced 0.4%
18,900 $1.52 Million
Q4 2018

Jan 14, 2019

SELL
$77.85 - $96.01 $19,462 - $24,002
-250 Reduced 1.3%
18,975 $1.75 Million
Q3 2018

Oct 11, 2018

BUY
$88.91 - $98.84 $444 - $494
5 Added 0.03%
19,225 $1.82 Million
Q2 2018

Jul 17, 2018

SELL
$89.78 - $106.23 $114,918 - $135,974
-1,280 Reduced 6.24%
19,220 $1.78 Million
Q1 2018

Apr 09, 2018

SELL
$92.01 - $123.21 $41,404 - $55,444
-450 Reduced 2.15%
20,500 $1.94 Million
Q4 2017

Jan 11, 2018

SELL
$89.56 - $98.21 $63,856 - $70,023
-713 Reduced 3.29%
20,950 $2.03 Million
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $1.51 Million - $1.93 Million
21,663
21,663 $1.93 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $327B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Home Federal Bank Of Tennessee Portfolio

Follow Home Federal Bank Of Tennessee and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Home Federal Bank Of Tennessee, based on Form 13F filings with the SEC.

News

Stay updated on Home Federal Bank Of Tennessee with notifications on news.